"Further analyses of clinical and immunological data from the CAN-003 clinical trial of CVacTM will be presented."
"As previously announced by Prima, topline data from the CAN-003 will be presented by Dr. Jeffrey Goh at the European Cancer Congress on October 1, 2013 in Amsterdam."
Joe, the way this reads to me, Dr Goh will present the "big picture" results from CAN003 and the poster presentation at SITC in November will go into the minutae and detailed breakdown.
one to get excited about, page-133
-
- There are more pages in this discussion • 89 more messages in this thread...
This thread is closed.
You may not reply to this discussion at this time.
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.5¢ |
Change
0.005(1.72%) |
Mkt cap ! $428.5M | |||
| Open | High | Low | Value | Volume |
| 28.5¢ | 30.5¢ | 28.5¢ | $469.8K | 1.579M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 297652 | 29.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.0¢ | 7500 | 2 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |